What Is Epithalon? Aging Claims Examined

Epithalon, also spelled Epitalon, is marketed for healthy aging. The claims are bold. The evidence in people is thin.
Where it comes from. Epithalon is a synthetic peptide made of four amino acids: alanine, glutamic acid, aspartic acid and glycine. It was developed in Russia in the late 1980s and 1990s, modeled on epithalamin, an extract of the pineal gland, the small gland in the brain that makes melatonin.
What studies have looked at. Much of the research comes from one research group and its collaborators. Studies in cells have looked at telomerase, an enzyme linked to the protective caps on chromosomes, and some animal studies have looked at lifespan and tumors. A few human reports exist, mostly from the same group.
What we do not know. Independent, high-quality human trials are lacking. Claims that Epithalon slows aging, lengthens telomeres in people or extends life have not been shown. Changing how cells divide could, in theory, carry risks, which is one reason people with a history of cancer are usually not candidates.
Regulation. Epithalon is not FDA-approved. FDA has raised safety concerns about compounding it, and its status can change.
Evidence-based healthy aging. Sleep, regular physical activity, not smoking, a balanced diet, managing blood pressure and blood sugar, and age-appropriate screening have strong evidence behind them.
Questions worth asking. What is known about Epithalon in people? Who did the research? What would make me a poor candidate?
Talking with a provider. A licensed provider can explain what is and is not known, review your health history and medications, and decide whether any option is appropriate. For many people the answer is no, and other evidence-based care may be a better fit. Compounded peptides are not FDA-approved, and a prescription is never guaranteed.
Related programs
This article is for educational purposes only and is not medical advice. Talk to a licensed provider about your situation.
